Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy.
Wang L; Xiao Y; Luo Y; Master RP; Mo J; Kim MC; Liu Y; Maharjan CK; Patel UM; De U; Carelock ME; Tithi TI; Li X; Shaffer DR; Guertin KR; Zhuang H; Moser E; Smalley KSM; Lv D; Zhou D; Zheng G; Zhang W.
J Exp Med
(Unknown)
Published: 2024
Addendum: Resolvins suppress tumor growth and enhance cancer therapy.
Sulciner ML; Serhan CN; Gilligan MM; Mudge DK; Chang J; Gartung A; Lehner KA; Bielenberg DR; Schmidt B; Dalli J; Greene ER; Gus-Brautbar Y; Piwowarski J; Mammoto T; Zurakowski D; Perretti M; Sukhatme VP; Kaipainen A; Kieran MW; Huang S; Panigrahy D.
J Exp Med
(Unknown)
Published: 2024
The effector program of human CD8 T cells supports tissue remodeling.
Delacher M; Schmidleithner L; Simon M; Stüve P; Sanderink L; Hotz-Wagenblatt A; Wuttke M; Schambeck K; Ruhland B; Hofmann V; Bittner S; Ritter U; Pant A; Helbich SS; Voss M; Lemmermann NA; Bessiri-Schake L; Bohn T; Eigenberger A; Menevse AN; Gebhard C; Strieder N; Abken H; Rehli M; Huehn J; Beckhove P; Hehlgans T; Junger H; Geissler EK; Prantl L; Werner JM; Schmidl C; Brors B; Imbusch CD; Feuerer M.
J Exp Med
(Unknown)
Published: 2024
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.
Bastard P; Gervais A; Taniguchi M; Saare L; Särekannu K; Le Voyer T; Philippot Q; Rosain J; Bizien L; Asano T; Garcia-Prat M; Parra-Martínez A; Migaud M; Tsumura M; Conti F; Belot A; Rivière JG; Morio T; Tanaka J; Javouhey E; Haerynck F; Duvlis S; Ozcelik T; Keles S; Tandjaoui-Lambiotte Y; Escoda S; Husain M; Pan-Hammarström Q; Hammarström L; Ahlijah G; Abi Haidar A; Soudee C; Arseguel V; Abolhassani H; Sahanic S; Tancevski I; Nukui Y; Hayakawa S; Chrousos GP; Michos A; Tatsi EB; Filippatos F; Rodriguez-Palmero A; Troya J; Tipu I; Meyts I; Roussel L; Ostrowski SR; Schidlowski L; Prando C; Condino-Neto A; Cheikh N; Bousfiha AA; El Bakkouri J; COVID
Clinicians; GEN-COVID Study Group; COVID Human Genetic
Effort; Peterson P; Pujol A; Lévy R; Quartier P; Vinh DC; Boisson B; Béziat V; Zhang SY; Borghesi A; Pession A; Andreakos E; Marr N; Mentis AA; Mogensen TH; Rodríguez-Gallego C; Soler-Palacin P; Colobran R; Tillmann V; Neven B; Trouillet-Assant S; Brodin P; Abel L; Jouanguy E; Zhang Q; Martinón-Torres F; Salas A; Gómez-Carballa A; Gonzalez-Granado LI; Kisand K; Okada S; Puel A; Cobat A; Casanova JL.
J Exp Med
(Unknown)
Published: 2024
A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation.
Lui VG; Hoenig M; Cabrera-Martinez B; Baxter RM; Garcia-Perez JE; Bailey O; Acharya A; Lundquist K; Capera J; Matusewicz P; Hartl FA; D'Abramo M; Alba J; Jacobsen EM; Niewolik D; Lorenz M; Pannicke U; Schulz AS; Debatin KM; Schamel WW; Minguet S; Gumbart JC; Dustin ML; Cambier JC; Schwarz K; Hsieh EWY.
J Exp Med
(Unknown)
Published: 2023
The guanine nucleotide exchange factor Rin-like controls Tfh cell differentiation via CD28 signaling.
Sandner L; Alteneder M; Rica R; Woller B; Sala E; Frey T; Tosevska A; Zhu C; Madern M; Khan M; Hoffmann P; Schebesta A; Taniuchi I; Bonelli M; Schmetterer K; Iannacone M; Kuka M; Ellmeier W; Sakaguchi S; Herbst R; Boucheron N.
J Exp Med
(Unknown)
Published: 2023
Targeting helminths: The expanding world of type 2 immune effector mechanisms.
J Exp Med
(Unknown)
Published: 2023
Golnaz Vahedi: My environment enables me to achieve impossible goals.
J Exp Med
(Unknown)
Published: 2023
TLR7/8 stress response drives histiocytosis in SLC29A3 disorders.
Shibata T; Sato R; Taoka M; Saitoh SI; Komine M; Yamaguchi K; Goyama S; Motoi Y; Kitaura J; Izawa K; Yamauchi Y; Tsukamoto Y; Ichinohe T; Fujita E; Hiranuma R; Fukui R; Furukawa Y; Kitamura T; Takai T; Tojo A; Ohtsuki M; Ohto U; Shimizu T; Ozawa M; Yoshida N; Isobe T; Latz E; Mukai K; Taguchi T; Hemmi H; Akira S; Miyake K.
J Exp Med
(Unknown)
Published: 2023
Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses.
Chancellor A; Alan Simmons R; Khanolkar RC; Nosi V; Beshirova A; Berloffa G; Colombo R; Karuppiah V; Pentier JM; Tubb V; Ghadbane H; Suckling RJ; Page K; Crean RM; Vacchini A; De Gregorio C; Schaefer V; Constantin D; Gligoris T; Lloyd A; Hock M; Srikannathasan V; Robinson RA; Besra GS; van der Kamp MW; Mori L; Calogero R; Cole DK; De Libero G; Lepore M.
J Exp Med
(Unknown)
Published: 2023
Distinct inflammatory Th17 subsets emerge in autoimmunity and infection.
Bouch RJ; Zhang J; Miller BC; Robbins CJ; Mosher TH; Li W; Krupenko SA; Nagpal R; Zhao J; Bloomfeld RS; Lu Y; Nikiforov MA; Song Q; He Z.
J Exp Med
(Unknown)
Published: 2023
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients.
Gervais A; Rovida F; Avanzini MA; Croce S; Marchal A; Lin SC; Ferrari A; Thorball CW; Constant O; Le Voyer T; Philippot Q; Rosain J; Angelini M; Pérez Lorenzo M; Bizien L; Achille C; Trespidi F; Burdino E; Cassaniti I; Lilleri D; Fornara C; Sammartino JC; Cereda D; Marrocu C; Piralla A; Valsecchi C; Ricagno S; Cogo P; Neth O; Marín-Cruz I; Pacenti M; Sinigaglia A; Trevisan M; Volpe A; Marzollo A; Conti F; Lazzarotto T; Pession A; Viale P; Fellay J; Ghirardello S; Aubart M; Ghisetti V; Aiuti A; Jouanguy E; Bastard P; Percivalle E; Baldanti F; Puel A; MacDonald MR; Rice CM; Rossini G; Murray KO; Simonin Y; Nagy A; Barzon L; Abel L; Diamond MS; Cobat A; Zhang SY; Casanova JL; Borghesi A.
J Exp Med
(Unknown)
Published: 2023